Skip to main content
. 2021 Dec 9;2021(12):CD010120. doi: 10.1002/14651858.CD010120.pub3
Study Reason for exclusion
Alloway 1993 Randomised controlled trial, but participants with renal insufficiency, history of gastrointestinal adverse events to non‐steroidal anti‐inflammatory drugs, peptic ulcer or gastritis, or any other contraindication to indomethacin were included in the trial but placed in the triamcinolone group (non‐randomised); other participants were randomised; data for randomised participants were not reported separately
Arnold 1988 Review
Bach 1979 Observational study
Cunovic 1973 Observational study
Cuq 1973 Observational study
Ecker‐Schlipf 2009 Wrong study type ‐ summary of the article Janssens 2008a
Janssens 2009 Wrong study type ‐ Dutch translation of Janssens 2008a
Kudaeva 2007 Wrong population ‐ not acute gout (participants with acute arthritis for > 3 weeks)
Navarra 2007 Meta‐analysis of different randomised trials of etoricoxib sponsored by the drug company Merck
NCT00997581 Study withdrawn
Reardon 1980 Study drug (feprazone) no longer available
Ruotsi 1978 Study drug (proquazone) no longer available
Steurer 2016 Wrong study type ‐ summary of Janssens 2008a and Rainer 2016
Tumrasvin 1985 Wrong comparator ‐ comparison of 2 different doses of the same drug
Valdes 1987 Wrong comparator ‐ comparison of 2 different doses of the same drug
Weiner 1979 Study drug (fenoprofen) no longer available
Werlen 1996 Observational study
Xu 2015 Wrong population: patients with peptic ulcer haemorrhage and acute gout